{
  "oncoTreeVersion": "oncotree_2019_12_01",
  "ncitVersion": "19.03d",
  "levels":
  [
    {
      "levelOfEvidence": "LEVEL_1",
      "description": "FDA-recognized biomarker predictive of response to an FDA-approved drug in this indication",
      "htmlDescription": "<span><b>FDA-recognized</b> biomarker predictive of response to an <b>FDA-approved</b> drug <b>in this indication</b></span>",
      "colorHex": "#33A02C"
    },
    {
      "levelOfEvidence": "LEVEL_2",
      "description": "Standard care biomarker recommended by the NCCN or other expert panels predictive of response to an FDA-approved drug in this indication",
      "htmlDescription": "<span><b>Standard care</b> biomarker recommended by the NCCN or other expert panels predictive of response to an <b>FDA-approved drug</b> in this indication</span>",
      "colorHex": "#1F78B4"
    },
    {
      "levelOfEvidence": "LEVEL_3A",
      "description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication",
      "htmlDescription": "<span><b>Compelling clinical evidence</b> supports the biomarker as being predictive of response to a drug <b>in this indication</b> but neither biomarker and drug are standard of care</span>",
      "colorHex": "#984EA3"
    },
    {
      "levelOfEvidence": "LEVEL_3B",
      "description": "Standard care or investigational biomarker predictive of response to an FDA-approved or investigational drug in another indication",
      "htmlDescription": "<span><b>Standard care</b> or <b>investigational</b> biomarker predictive of response to an <b>FDA-approved</b> or <b>investigational</b> drug in another indication</span>",
      "colorHex": "#BE98CE"
    },
    {
      "levelOfEvidence": "LEVEL_4",
      "description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug",
      "htmlDescription": "<span><b>Compelling biological evidence</b> supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care</span>",
      "colorHex": "#424242"
    },
    {
      "levelOfEvidence": "LEVEL_Dx1",
      "description": "FDA and/or professional guideline-recognized biomarker required for diagnosis in this indication",
      "htmlDescription": "<span><b>FDA and/or professional guideline-recognized</b> biomarker required for diagnosis in this indication</span>",
      "colorHex": "#33A02C"
    },
    {
      "levelOfEvidence": "LEVEL_Dx2",
      "description": "FDA and/or professional guideline-recognized biomarker that supports diagnosis in this indication",
      "htmlDescription": "<span><b>FDA and/or professional guideline-recognized</b> biomarker that supports diagnosis in this indication</span>",
      "colorHex": "#1F78B4"
    },
    {
      "levelOfEvidence": "LEVEL_Dx3",
      "description": "Biomarker that may assist disease diagnosis in this indication based on clinical evidence",
      "htmlDescription": "<span>Biomarker that <b>may assist disease diagnosis</b> in this indication based on <b>clinical evidence</b></span>",
      "colorHex": "#984EA3"
    },
    {
      "levelOfEvidence": "LEVEL_Fda1",
      "description": "Companion Diagnostics",
      "htmlDescription": "Companion Diagnostics",
      "colorHex": ""
    },
    {
      "levelOfEvidence": "LEVEL_Fda2",
      "description": "Cancer Mutations with Evidence of Clinical Significance",
      "htmlDescription": "Cancer Mutations with Evidence of Clinical Significance",
      "colorHex": ""
    },
    {
      "levelOfEvidence": "LEVEL_Fda3",
      "description": "Cancer Mutations with Potential of Clinical Significance",
      "htmlDescription": "Cancer Mutations with Potential of Clinical Significance",
      "colorHex": ""
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "description": "FDA and/or professional guideline-recognized biomarker prognostic in this indication based on well-powered studie(s)",
      "htmlDescription": "<span><b>FDA and/or professional guideline-recognized</b> biomarker prognostic in this indication based on <b>well-powered studie(s)</b></span>",
      "colorHex": "#33A02C"
    },
    {
      "levelOfEvidence": "LEVEL_Px2",
      "description": "FDA and/or professional guideline-recognized biomarker prognostic in this indication based on a single or multiple small studies",
      "htmlDescription": "<span><b>FDA and/or professional guideline-recognized</b> biomarker prognostic in this indication based on <b>a single or multiple small studies</b></span>",
      "colorHex": "#1F78B4"
    },
    {
      "levelOfEvidence": "LEVEL_Px3",
      "description": "Biomarker is prognostic in this indication based on clinical evidence in well-powered studies",
      "htmlDescription": "<span>Biomarker is prognostic in this indication based on <b>clinical evidence</b> in <b>well-powered studies</b></span>",
      "colorHex": "#984EA3"
    },
    {
      "levelOfEvidence": "LEVEL_R1",
      "description": "Standard care biomarker predictive of resistance to an FDA-approved drug in this indication",
      "htmlDescription": "<span><b>Standard of care</b> biomarker predictive of <b>resistance</b> to an <b>FDA-approved</b> drug <b>in this indication</b></span>",
      "colorHex": "#EE3424"
    },
    {
      "levelOfEvidence": "LEVEL_R2",
      "description": "Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug",
      "htmlDescription": "<span><b>Compelling clinical evidence</b> supports the biomarker as being predictive of <b>resistance</b> to a drug</span>",
      "colorHex": "#F79A92"
    }
  ],
  "dataVersion":
  {
    "version": "v3.16",
    "date": "09/06/2022"
  },
  "appVersion":
  {
    "version": "v3.10.0",
    "major": 3,
    "minor": 10,
    "patch": 0,
    "suffixTokens":
    [],
    "stable": true
  },
  "apiVersion":
  {
    "version": "v1.4.0",
    "major": 1,
    "minor": 4,
    "patch": 0,
    "suffixTokens":
    [],
    "stable": true
  },
  "publicInstance": false
}
